Skip to content
Open access

Pre-Radiotherapy Risk Prediction of Grade ≥2 Radiotherapy-Induced Lymphopenia in Breast Cancer: A Single-Center Interpretable Machine Learning Study

Nov 2026 · International Journal of General Medicine · 0 citations · 37 references

Abstract

Background: Radiotherapy-induced lymphopenia (RIL) is a clinically relevant hematologic toxicity in patients with breast cancer, yet early risk assessment before radiotherapy remains challenging because existing approaches often rely on dosimetric parameters or hematologic changes observed during treatment. This study aimed to develop and internally validate an interpretable machine-learning (ML) model using routinely available pre-radiotherapy clinical and laboratory variables to estimate the risk of grade ≥2 RIL in patients with breast cancer. Methods: We retrospectively studied 167 patients with breast cancer treated at Siyang Hospital between 2020 and 2025, including 56 with grade ≥2 RIL. Six predictors preselected from 20 routine pre-radiotherapy variables were used to compare seven algorithms through repeated nested fivefold cross-validation (20 repetitions; fivefold inner tuning). Performance was evaluated using patient-level mean out-of-fold predictions. The final model was interpreted using Shapley additive explanations and implemented as a research calculator. Irradiation extent and dosimetric parameters were excluded. Results: Random forest achieved an area under the receiver operating characteristic curve of 0.801 (95% confidence interval [CI]: 0.722– 0.871), an area under the precision–recall curve of 0.750 (95% CI: 0.647–0.842), and a Brier score of 0.159 (95% CI: 0.128–0.193). Sensitivity was 60.7% and specificity 89.2%; this moderate sensitivity limits identification of patients who develop grade ≥2 RIL. The final model included age, absolute neutrophil count, absolute lymphocyte count, absolute monocyte count, lactate dehydrogenase, and prealbumin. Conclusion: This internally validated model showed moderate discrimination. Early predictor preselection may inflate performance estimates, and independent external validation is required. The calculator remains a research tool and should not guide clinical decisions.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.